Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ferdinand Gebauer

1PUBLICATIONS
7CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo.

Gefei Du, Shirin Emtenani, Dennis Niese

Pageof 1

Frequent Collaborators

1 joint publications

Shirin Emtenani

1 joint publications

Jelena Šimunović

1 joint publications

Gerd Geerling

1 joint publications

Markus H Hoffmann

1 joint publications

Katja Bieber

1 joint publications

Stephanie Goletz

1 joint publications

Sabrina Patzelt

Frequent Collaborators

1 joint publications

Shirin Emtenani

1 joint publications

Jelena Šimunović

1 joint publications

Gerd Geerling

1 joint publications

Markus H Hoffmann

Top Related Videos

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on : Feb 02, 2024

2.4K
See more related videos

Top Related Videos

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on : Feb 02, 2024

2.4K
See more related videos